US 9416190
Mesothelin antibodies and methods for eliciting potent antitumor activity
granted A61KA61K2039/505A61P
Quick answer
US patent 9416190 (Mesothelin antibodies and methods for eliciting potent antitumor activity) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00, A61P35/04